Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Shares Outstanding (Diluted Average) (2020 - 2025)

Traws Pharma's Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $8.4 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $8.4 million for Q4 2025, up 439.48% from a year ago — trailing twelve months through Dec 2025 was $8.4 million (up 439.48% YoY), and the annual figure for FY2025 was $8.4 million, up 439.48%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $8.4 million at Traws Pharma, down from $8.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $21.0 million in Q2 2023 to a low of $839243.0 in Q3 2023.
  • The 5-year median for Shares Outstanding (Diluted Average) is $11.7 million (2021), against an average of $11.2 million.
  • The sharpest move saw Shares Outstanding (Diluted Average) crashed 95.99% in 2023, then surged 817.17% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $16.8 million in 2021, then rose by 24.22% to $20.9 million in 2022, then crashed by 95.98% to $839554.0 in 2023, then skyrocketed by 84.94% to $1.6 million in 2024, then soared by 439.48% to $8.4 million in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $8.4 million, $8.8 million, and $5.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.